Publications by authors named "Jorg Petersen"

Claim this Profile
[
[Treatment strategies for hepatitis B, C and D].
Jörg Petersen, Peter Buggisch

MMW Fortschr Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ReLink strategy in diagnosed-but-untreated hepatitis C-positive patients in Germany: report from a single center.
Sarah Lange, Christina Baehr, Nur Irem Cakman-Hinrichs, Katharina Cron, Hannah Fengels, Jörg Petersen

Z Gastroenterol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS).
Lisa Sandmann, Thomas Berg, Katja Deterding, Nadine Fischer, Holger Hinrichsen, Jörg Petersen

Z Gastroenterol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Lisa Sandmann, Thomas Berg, Katja Deterding, Nadine Fischer, Holger Hinrichsen, Jörg Petersen

Z Gastroenterol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
Florian van Bömmel, Kerstin Stein, Renate Heyne, Jörg Petersen, Peter Buggisch

J Hepatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Lisa Sandmann, Jörg Petersen, Markus Cornberg

Z Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, Claus Niederau, Frank Tacke, Jörg Petersen

Z Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany.
Anne-Christin Beatrice Wilde, Charlotte Lieb, Elise Leicht, Lena Maria Greverath, Lara Marleen Steinhagen, Jörg Petersen

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnostic and prognostic significance of α-fetoprotein in hepatocellular carcinoma].
Jendrik Becker-Assmann, Mohammad H Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Jörg Petersen

Chirurg· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.
Patrick Marcellin, Qing Xie, Seung Woon Paik, Robert Flisiak, Teerha Piratvisuth, Jörg Petersen

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons to consider early treatment in chronic hepatitis B patients.
Apostolos Koffas, Jörg Petersen, Patrick T Kennedy

Antiviral Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
Patrick Marcellin, David K Wong, William Sievert, Peter Buggisch, Jörg Petersen

Liver Int· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Stefan Traussnigg, Jörn M Schattenberg, Münevver Demir, Johannes Wiegand, Andreas Geier, Jörg Petersen

Lancet Gastroenterol Hepatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
Qiushi Chen, Turgay Ayer, Emily Bethea, Fasiha Kanwal, Xiaojie Wang, Jorg Petersen

BMJ Open· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, Florin A Caruntu, Won Young Tak, Jörg Petersen

Dig Dis Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, Florin A Caruntu, Won Young Tak, Jörg Petersen

Dig Dis Sci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry.
Georg Dultz, Tobias Müller, Jörg Petersen, Stefan Mauss, Tim Zimmermann

Drugs Aging· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B.
Pietro Lampertico, Diethelm Messinger, Markus Cornberg, Maurizia Brunetto, Jörg Petersen

Ann Gastroenterol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Stop-and-watch strategy after cessation of nucleos(t)ide analogue therapy in HBeAg-negative patients".
Thomas Berg, Jörg Petersen,

J Hepatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Nucleos(t)ide analogue interruption: Alternative approach to intrahepatic set point for spontaneous control of HBV replication?".
Thomas Berg, Jörg Petersen,

J Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
Julia Dietz, Simone Susser, Johannes Vermehren, Kai-Henrik Peiffer, Georgios Grammatikos, Jörg Petersen

Gastroenterology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term and long-term results of endovascular and open repair of abdominal aortic aneurysms in Germany.
Christian-Alexander Behrendt, Art Sedrakyan, Henrik Christian Rieß, Franziska Heidemann, Tilo Kölbel, Jörg Petersen

J Vasc Surg· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
Thomas Berg, Karl-Georg Simon, Stefan Mauss, Eckart Schott, Renate Heyne, Jörg Petersen

J Hepatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.
Katja Giersch, Maria Homs, Tassilo Volz, Martina Helbig, Lena Allweiss, Jörg Petersen

Sci Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus infection.
Harry L A Janssen, Henry Lik Yuen Chan, Jorg Petersen

Best Pract Res Clin Gastroenterol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis